Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | UNCY |
---|---|---|
09:32 ET | 49475 | 0.53001 |
09:33 ET | 17934 | 0.53 |
09:35 ET | 10388 | 0.5301 |
09:37 ET | 1594 | 0.5305 |
09:39 ET | 3400 | 0.5302 |
09:42 ET | 13595 | 0.525 |
09:44 ET | 1900 | 0.5303 |
09:46 ET | 2300 | 0.5236 |
09:48 ET | 3223 | 0.5236 |
09:50 ET | 25753 | 0.5217 |
09:51 ET | 3977 | 0.5217 |
09:53 ET | 13015 | 0.5217 |
09:55 ET | 29348 | 0.51625 |
09:57 ET | 8720 | 0.5142 |
10:00 ET | 800 | 0.519799 |
10:02 ET | 41597 | 0.5059 |
10:04 ET | 23800 | 0.5081 |
10:06 ET | 3624 | 0.5099 |
10:08 ET | 13218 | 0.5061 |
10:09 ET | 2650 | 0.5061 |
10:11 ET | 11059 | 0.5079 |
10:13 ET | 1500 | 0.5071 |
10:15 ET | 2860 | 0.510449 |
10:18 ET | 2200 | 0.5071 |
10:20 ET | 1850 | 0.5101 |
10:22 ET | 2335 | 0.5099 |
10:24 ET | 2850 | 0.5077 |
10:26 ET | 6260 | 0.509 |
10:27 ET | 33966 | 0.507 |
10:29 ET | 6985 | 0.5069 |
10:31 ET | 8546 | 0.504651 |
10:33 ET | 12500 | 0.506799 |
10:38 ET | 2100 | 0.5068 |
10:40 ET | 21662 | 0.5078 |
10:42 ET | 18274 | 0.5107 |
10:44 ET | 38066 | 0.5163 |
10:45 ET | 2200 | 0.5163 |
10:47 ET | 945 | 0.5122 |
10:49 ET | 21864 | 0.5101 |
10:51 ET | 4500 | 0.5101 |
10:54 ET | 417 | 0.5101 |
10:56 ET | 450 | 0.5101 |
10:58 ET | 1499 | 0.5101 |
11:00 ET | 290 | 0.5101 |
11:02 ET | 1150 | 0.5101 |
11:03 ET | 5873 | 0.5101 |
11:05 ET | 605 | 0.51005 |
11:07 ET | 8105 | 0.5102 |
11:12 ET | 347 | 0.51 |
11:14 ET | 1800 | 0.51 |
11:16 ET | 103699 | 0.5003 |
11:18 ET | 80631 | 0.49755 |
11:20 ET | 14650 | 0.495 |
11:21 ET | 41121 | 0.493251 |
11:23 ET | 14623 | 0.4972 |
11:25 ET | 7777 | 0.4971 |
11:27 ET | 21441 | 0.49 |
11:30 ET | 6835 | 0.4901 |
11:32 ET | 11289 | 0.4901 |
11:34 ET | 300 | 0.4901 |
11:36 ET | 87586 | 0.48 |
11:38 ET | 9002 | 0.4801 |
11:39 ET | 29942 | 0.4856 |
11:41 ET | 28199 | 0.4801 |
11:43 ET | 1250 | 0.485599 |
11:45 ET | 24014 | 0.48 |
11:48 ET | 3441 | 0.48 |
11:50 ET | 39577 | 0.474857 |
11:52 ET | 24420 | 0.4711 |
11:54 ET | 21480 | 0.4722 |
11:56 ET | 73706 | 0.4679 |
11:57 ET | 98147 | 0.4699 |
11:59 ET | 16980 | 0.462999 |
12:01 ET | 111812 | 0.4689 |
12:03 ET | 137650 | 0.4576 |
12:06 ET | 8645 | 0.46 |
12:08 ET | 38326 | 0.4599 |
12:10 ET | 3566 | 0.4658 |
12:12 ET | 5020 | 0.4688 |
12:14 ET | 113030 | 0.4851 |
12:15 ET | 29027 | 0.4798 |
12:17 ET | 8896 | 0.4794 |
12:19 ET | 42843 | 0.4702 |
12:21 ET | 30619 | 0.4703 |
12:24 ET | 3550 | 0.4797 |
12:26 ET | 23870 | 0.4691 |
12:28 ET | 9000 | 0.4624 |
12:30 ET | 29269 | 0.4721 |
12:32 ET | 9265 | 0.472099 |
12:33 ET | 114544 | 0.4585 |
12:35 ET | 26984 | 0.4589 |
12:37 ET | 12350 | 0.459001 |
12:39 ET | 139202 | 0.4502 |
12:42 ET | 544 | 0.4501 |
12:44 ET | 94468 | 0.45 |
12:46 ET | 15325 | 0.4515 |
12:48 ET | 4627 | 0.4516 |
12:50 ET | 6900 | 0.4515 |
12:51 ET | 5297 | 0.4515 |
12:53 ET | 15093 | 0.45 |
12:55 ET | 4000 | 0.4501 |
12:57 ET | 11946 | 0.4516 |
01:00 ET | 15600 | 0.452787 |
01:02 ET | 2350 | 0.452 |
01:04 ET | 12966 | 0.455 |
01:06 ET | 4150 | 0.4584 |
01:08 ET | 5608 | 0.4626 |
01:09 ET | 31170 | 0.459 |
01:11 ET | 14440 | 0.4527 |
01:13 ET | 12200 | 0.4584 |
01:15 ET | 7800 | 0.4558 |
01:18 ET | 100 | 0.4558 |
01:20 ET | 1200 | 0.4558 |
01:22 ET | 6300 | 0.4541 |
01:24 ET | 626 | 0.455 |
01:26 ET | 3530 | 0.4551 |
01:27 ET | 19904 | 0.4595 |
01:29 ET | 2204 | 0.4576 |
01:31 ET | 7262 | 0.4681 |
01:33 ET | 8166 | 0.4658 |
01:36 ET | 5474 | 0.46 |
01:38 ET | 1700 | 0.4646 |
01:40 ET | 2200 | 0.4629 |
01:42 ET | 5827 | 0.467 |
01:44 ET | 3305 | 0.467 |
01:45 ET | 11290 | 0.4736 |
01:47 ET | 7900 | 0.4718 |
01:49 ET | 6400 | 0.4751 |
01:51 ET | 10377 | 0.47465 |
01:54 ET | 300 | 0.47465 |
01:56 ET | 8877 | 0.4778 |
01:58 ET | 1600 | 0.4743 |
02:00 ET | 500 | 0.4784 |
02:02 ET | 1370 | 0.474249 |
02:03 ET | 2600 | 0.4785 |
02:05 ET | 420 | 0.4701 |
02:07 ET | 180 | 0.4785 |
02:09 ET | 400 | 0.475 |
02:12 ET | 12005 | 0.48 |
02:14 ET | 2827 | 0.4701 |
02:16 ET | 106 | 0.4701 |
02:18 ET | 2891 | 0.4701 |
02:20 ET | 500 | 0.4702 |
02:21 ET | 687 | 0.4728 |
02:23 ET | 100 | 0.47011 |
02:25 ET | 2387 | 0.473 |
02:27 ET | 2685 | 0.4738 |
02:30 ET | 1410 | 0.478 |
02:32 ET | 2000 | 0.48 |
02:34 ET | 12125 | 0.477 |
02:36 ET | 3244 | 0.47765 |
02:38 ET | 5885 | 0.4828 |
02:39 ET | 8230 | 0.486199 |
02:41 ET | 650 | 0.4851 |
02:43 ET | 6051 | 0.4851 |
02:45 ET | 14500 | 0.4804 |
02:48 ET | 12300 | 0.4848 |
02:50 ET | 18198 | 0.4848 |
02:52 ET | 300 | 0.48 |
02:54 ET | 2700 | 0.4844 |
02:56 ET | 720 | 0.4834 |
02:57 ET | 1600 | 0.4833 |
02:59 ET | 800 | 0.4801 |
03:01 ET | 1041 | 0.4832 |
03:06 ET | 1300 | 0.4848 |
03:08 ET | 40190 | 0.4899 |
03:10 ET | 25391 | 0.4899 |
03:12 ET | 1099 | 0.49 |
03:14 ET | 3875 | 0.4899 |
03:15 ET | 116100 | 0.4899 |
03:17 ET | 9530 | 0.481 |
03:19 ET | 1614 | 0.4802 |
03:21 ET | 11896 | 0.484 |
03:24 ET | 2400 | 0.4801 |
03:26 ET | 600 | 0.48 |
03:28 ET | 300 | 0.4801 |
03:30 ET | 700 | 0.4801 |
03:33 ET | 838 | 0.4801 |
03:35 ET | 200 | 0.483 |
03:37 ET | 1000 | 0.4831 |
03:39 ET | 100 | 0.4829 |
03:42 ET | 300 | 0.4832 |
03:44 ET | 4100 | 0.4818 |
03:46 ET | 1100 | 0.4806 |
03:48 ET | 2400 | 0.4837 |
03:50 ET | 32497 | 0.4777 |
03:51 ET | 1903 | 0.4778 |
03:53 ET | 11534 | 0.47295 |
03:55 ET | 11553 | 0.4769 |
03:57 ET | 15487 | 0.4825 |
04:00 ET | 20059 | 0.4844 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Unicycive Therapeutics Inc | 50.3M | -1.7x | --- |
Provectus Biopharmaceuticals Inc | 45.7M | -17.1x | --- |
Barinthus Biotherapeutics PLC | 55.2M | -0.9x | --- |
Immix Biopharma Inc | 48.6M | -2.0x | --- |
Vicapsys Life Sciences Inc | 48.4M | -44.5x | --- |
Xilio Therapeutics Inc | 47.9M | -0.5x | --- |
Unicycive Therapeutics, Inc. is a biotechnology company that is developing treatments for certain medical conditions. Its programs are focused on kidney disease, an area that has the potential to offer medical benefits. Its development programs are focused on two novel therapies: Oxylanthanum Carbonate, and UNI 494. Oxylanthanum Carbonate is a novel investigational phosphate binding agent being developed for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis. UNI-494 is a patent-protected new chemical entity in clinical development for the treatment of conditions related to acute kidney injury. Oxylanthanum Carbonate and UNI 494 were initially developed by and licensed to it from Spectrum Pharmaceuticals (Spectrum) and Sphaera Pharma, respectively.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $50.3M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 94.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.23 |
EPS | $-0.28 |
Book Value | $-0.11 |
P/E Ratio | -1.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.